In agreement with the ability of HDL to reduce endothelial VCAM-1 expression, atherosclerosis progression and cardiovascular risk [45], we demonstrated that patients with low HDL-S1P levels had an altered capacity to inhibit VCAM-1 expression in human endothelial cells together with a CAC score > 100. This evidence concerns the gene VCAM1 and atherosclerosis.